Anti-arthritic activity of a classical Ayurvedic formulation Vatari Guggulu in rats

10.1016/j.jtcme.2015.08.007

Madhavi G. Patel；Kilambi Pundarikakshudu

Vatari Guggulu ； Formaldehyde ； Adjuvant induced arthritis ； ESR ； Haemoglobin ； Cholesterol

Journal of Traditional and Complementary Medicine

6卷4期（2016 / 10 / 01）

389 - 394

英文

In India, Vatari Guggulu has been traditionally used in the Ayurvedic system of medicine to treat rheumatoid arthritis (RA). The current study was undertaken to evaluate anti-arthritic activity of alcoholic extract of Vatari Guggulu in rats. Arthritis was induced by administration of formaldehyde (2%v/v) or Complete Freund's Adjuvant (CFA) into the sub-plantar surface of left hind paw of the animals. The extract was administered to the rats by oral gavages in different doses. Joint swelling was measured in formaldehyde induced arthritis. Various physical, biochemical and histopathological parameters were determined in CFA induced arthritis. Vatari Guggulu extract (VGE) produced significant (P ＜ 0.05) inhibition of joint swelling in both formaldehyde and CFA induced arthritis. The treatment also brought to normalcy the increased white blood cell (WBC) count, rheumatoid factor (RF), erythrocyte sedimentation rate (ESR), cholesterol, triglycerides and LDL with an enhancement of haemoglobin (Hb) levels and red blood cell (RBC) count. These effects were found to be dose dependent. These effects were comparable with standard drug indomethacin. Histo-pathological studies of the ankles of VGE treated animals exhibited significant improvements. VGE did not show any toxic symptoms even at a dose of 2000 mg/kg in acute toxicity studies on rats. Thus, Vatari Guggulu, a classical Ayurvedic formulation of the Indian System of Medicine, exhibited significant anti-arthritic activity in formaldehyde and CFA induced arthritis in rats. This study corroborates the claims of Ayurveda on Vatari Guggulu.

1. (2008).The Ayurvedic Pharmacopoeia of India, Part II. vol. II.New Delhi, India:Ministry of Health and family Welfare, Government of India.
2. Anderson, GD,Hauser, SD,McGarity, KL,Bremer, ME,Isakson, PC,Gregory, SA(1996).Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.J Clin Invest,97,2672-2679.
3. Anonymous(2003).Ayurvedic Formulary of India. Part I.New Delhi, India:Ministry of Health and Family Welfare, Government of India.
4. Brinckerhoff, CE,Coffey, JW,Sullivan, AC(1983).Inflammation and collagenase production in rats with adjuvant arthritis reduced with 13-cis-retinoic acid.Science,221,756-765.
5. Brownlee, G.(1950).Effect of deoxycortone and ascorbic acid on formaldehyde induced arthritis in normal and adrenalectomised rats.Lancet,1,157.
6. Cain, CK,Francis, JM,Plone, MA,Emerich, DF,Lindner, MD(1997).Pain-related disability and effects of chronic morphine in adjuvant induced arthritis model of chronic pain.Physiol Behav,62,199-205.
7. Duwiejua, M,Setline, IJ,Waterman, PG,Chapman, J,Mango, GJ,Provan, GJ(1993).Anti-inflammatory activity of resins from some species of the plant family Burser-aceae.Planta Med,59,12-16.
8. Fuchs, HA,Kaye, JJ,Callahan, LF(1989).Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease.J Rheumatol,16,585-591.
9. Grunfeld, C,Feingold, KR(1992).Role of cytokines in inducing hyperlipidemia.Diabetes,41,97-101.
10. Hochberg, MC,Arnold, CM,Hogans, BB,Spivak, JL(1988).Serum immune reactive erythropoietin in rheumatoid arthritis: impaired response to anaemia.Arthritis Rheuma,31,1318-1321.
11. Kasper, DL(ed.),Braunwald, E(ed.),Fauci, AS(ed.),Hauser, SL(ed.),Longo, DL(ed.),Jameson, JL(ed.)(2005).Harrison's Principles of Internal Medicine.New York, NY:McGraw Hill.
12. Kimura, I,Yoshikawa, M,Kobayashi, S(2001).New triterpenes, myrrhanol A and myrrhanone A, from guggul-gum resins, and their potent anti-inflammatory effect on adjuvant-induced air-pouch granuloma of mice.Bioorg Med Chem Lett,11,985-989.
13. Maria, M,Engeniusz, M,Miroslaw, K,Maria, K,Iwona, P(1983).Adjuvant induced disease in rats: clinical findings and morphological and biochemical changes in blood and histological changes in internal organs.Rheumatology,21,213-245.
14. Newbould, BB(1963).Chemotherapy of arthritis induced in rats by mycobacterial adjuvant.Br J Pharmacol Chemother,21,127-136.
15. OECD(2001).Guidance Document on Acute Oral Toxicity Testing.Paris, France:Organization for Economic Cooperation and Development, OECD Environment, Health and Safety Publications.
16. Rao, JK,Mihaliak, K,Kroenke, K,Bradley, J,Tierney, WM,Weinberger, M(1999).Use of complementary therapies for arthritis among patients of rheumatologists.Ann Intern Med,131,409-416.
17. Sabina, EP,Rasool, M(2007).Therapeutic efficacy of Indian Ayurvedic herbal formulation triphala on lipid peroxidation, antioxidant status and inflammatory mediator TNF-α in adjuvant-induced arthritic mice.Int J BiolChem,1,149-155.
18. Sattar, N,McCarey, DW,Capell, H,McInnes, IB(2003).Explaining how "high grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis.Circulation,108,2957-2963.
19. Sharad, MM,Arulmozhi, S,Chinmay, UK,Subhash, LB,Kakasaheb, RM(2011).Antiarthritic activity of standardised extract of Phyllanthus amarus in Freund's complete adjuvant induced arthritis.Biomed Aging Pathol,1,185-190.
20. Sharma, JN,Sharma, JN(1977).Comparison of the anti-inflammatory activity of Commiphora mukul (an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant.Arzneim Forsch,27,1455-1457.
21. Shishodia, S,Aggarwal, BB(2004).Guggulsterone inhibits NF-kappa B and I kappa B alpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis.JBiol Chem,279,47148-47158.
22. Singh, BB,Mishra, LC,Vinjamury, SP,Aquilina, N,Singh, VJ,Shepard, N(2003).The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcome study.Altern Ther Health Med.,9,74-79.
23. Weiss, G,Goodnough, LT(2005).Anemia of chronic disease.New Engl J Med,352,1011-1023.
24. Wolfe, F(1997).Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis.J Rheumatol,24,1477-1485.